GL – Globe Life Inc.

Globe Life Inc. (NYSE: GL) Monthly Stock Report – November 05, 2025

Globe Life Inc. (NYSE: GL), headquartered in McKinney, Texas, is a significant player in the financial services sector, particularly within the life insurance industry. Founded in 1900 and known previously as Torchmark Corporation, Globe Life has consistently provided an array of life and supplemental health insurance products aimed primarily at lower middle- and middle-income households across the United States. With a diverse product line that includes whole and term life insurance, Medicare supplement insurance, and annuities, the company operates through three main segments: Life Insurance, Supplemental Health Insurance, and Investments. This strategic focus has solidified Globe Life’s position as a trusted provider in the market.

52-Week Price Performance Analysis

Over the past year, Globe Life Inc. has showcased an impressive bullish trend. The company’s stock price has generally risen, characterized by a supportive upward-sloping green trendline. Starting around $110, the stock has made significant strides, peaking above $150 before a recent pullback settled the price around $132.45.

Key Insights:

• Support and Resistance Levels: The established support level at approximately $110 has been crucial in helping the stock rebound from dips. Resistance appears to be around $150, where the price has struggled to break through on multiple occasions.
• Moving Averages: The stock has managed to stay above its 50-day moving average of $138.83 for most of the year, although it recently dipped below this mark, suggesting potential short-term weakness. This movement indicates that while the long-term bullish structure remains intact, current market conditions warrant careful observation.
• Momentum Indicators: Analyzing momentum, the stock has shown the ability to achieve higher highs and higher lows during the year, a strong indicator of upward trends. However, the recent retreat from peak levels raises questions about short-term volatility.

Investors should look for a potential breakout above the $150 resistance level to confirm renewed upward momentum, while also keeping an eye on the support line to gauge any reversal signals.

Financial Performance and Metrics

Financially, Globe Life has demonstrated a robust and stable performance characterized by solid revenue and strong profitability metrics. For the fiscal year, the company reported total revenues of approximately $5.94 billion, showcasing its significant market presence and operational efficiency.

Key Financial Metrics:

• EBITDA: Approximately $1.61 billion, reflecting healthy operational profitability and a favorable margin structure.
• Shares Outstanding: The company has 81,003,536 shares outstanding, with only a slight short interest of about 0.0212%, indicating limited bearish sentiment.
• Current Price and Valuation: The current stock price rests at $132.45, a notable undervaluation compared to the average analyst target of $166.45, suggesting a solid growth opportunity for investors.

Globe Life’s positive financial outlook casts a favorable light on investments, especially considering a significant increase in net income per diluted share of 38% year over year.

Recent News and Developments

Recent events surrounding Globe Life have significantly bolstered investor confidence.

• On July 29, 2025, the U.S. Attorney’s Office concluded its investigation into sales practices at its subsidiary, American Income Life, without any resultant enforcement action. This alleviation of regulatory concerns led to a 6.6% surge in stock price.

• Subsequently, on August 14, 2025, Globe Life announced a dual listing on the newly launched NYSE Texas exchange while retaining its primary listing on the NYSE. This strategic maneuver highlights its commitment to enhancing market presence and leveraging its Texas roots.

• Further, the third-quarter results released on October 22, 2025, revealed not only strong operational performance but also that the company repurchased 840,242 shares of its own stock, signaling confidence in its financial position and improving shareholder value.

These positive developments underscore a favorable outlook for Globe Life as it navigates market challenges and remains focused on growth prospects.

Market Sentiment and Analyst Recommendations

The analyst consensus on Globe Life is notably bullish, with ratings reflecting strong confidence in the company’s performance. With analyses from 11 analysts, the average recommendation stands at 1.73, indicating a strong buy sentiment.

Key Price Targets:

• Target High Price: $188.00
• Target Mean Price: $166.45
• Median Target Price: $167.00

Analysts point towards the potential significant upside opportunities, especially given recent performance and market conditions. For instance, TD Cowen has reaffirmed a buy rating, adjusting its price target to $182, further acknowledging the positive market context following the DOJ’s investigation closure.

Conclusion

In summary, Globe Life Inc. presents an attractive investment opportunity characterized by solid revenue growth, robust financial metrics, and favorable market sentiment. The combination of an undemanding current valuation versus projected price targets, as well as significant recent developments, positions the stock favorably for both growth and stability in an evolving financial landscape.

Investors should be vigilant about potential resistance levels and market sentiment trends moving forward, while capitalizing on the long-term upward trajectory that Globe Life Inc. has established in the life insurance sector.

Metric	Value
Market Cap	$10.7b
Total Debt	$2.7b
Total Cash	$365.5m
Shares Outstanding	81.0m
Float Shares	79.7m